About our Tests

Our infectious disease and gastrointestinal pathology specialists, as well as our exceptional turnaround times, complement these patient-friendly choices, creating an optimal outcome.

Correctly diagnosing bleeding and thrombotic disorders relies heavily on laboratory blood testing, as well as a thorough patient examination and medical history. AML offers a comprehensive and highly advanced test menu for these conditions.

The tests for bleeding disorders and thrombosis play several vital roles, including identifying defects in hemostasis, assessing the risk of thrombosis, monitoring anticoagulant therapy, investigating thrombotic conditions, and determining the cause of abnormal PT and aPTT test results. AML goes a step further by providing consultative reports, interpretations, FAQs, and expert insights to enhance the testing process.

Gaining insight into infectious diseases is crucial for developing effective care plans, especially for patients with complex or chronic infections. AML offers convenient specimen collection, comprehensive testing, and extensive support to provide actionable insights that help healthcare professionals deliver the best possible care.

Our testing menu covers a wide range of diseases, including hepatitis, tuberculosis (TB), human immunodeficiency virus (HIV), tick-borne diseases, and other infections. We use flexible tests and screens that account for resistant organisms and emerging strains of the most dangerous pathogens. Additionally, our integrated services, such as patient reminders and appointment scheduling, help optimize compliance during monitoring, treatment, and follow-up.

The COVID-19 pandemic has highlighted the challenges and opportunities in developing faster and more effective diagnostics for infectious diseases. Although vaccines have helped reduce the spread of COVID-19, new variants continue to pose a significant threat, particularly to unvaccinated individuals and high-risk communities.

As people return to work, school, and healthcare, there is a growing need for comprehensive, flexible, and adaptive testing programs to overcome barriers and ensure safety. While the focus has been on COVID-19, the lessons learned from the pandemic can provide valuable insights for preventing, diagnosing, and managing future epidemics.

AML offers a comprehensive range of tests to help healthcare professionals make informed and confident diagnostic and treatment decisions for infectious diseases. Our menu of quantitative and qualitative assays not only screens for and identifies pathogens but also assists in assessing treatment response and drug resistance and planning appropriate care.

Our infectious disease test menu includes:

• Viral hepatitis infection A-E
• HIV
• Tuberculosis
• Respiratory infections
• Vector-borne diseases

Early identification of diabetes risk is crucial in managing the disease, especially with the increasing obesity rates and aging population in the US. AML understands the urgency of diabetes prevention and management, and we offer an extensive range of laboratory testing for diabetes. Our testing services are designed to provide insights into diabetes risk, regardless of the patient's stage of care, and help you maintain continuity of care.

• Evaluating the risk of diabetes
• Distinguishing between different types of diabetes
• Tracking patients with diabetes

AML is committed to providing healthcare for women at every stage of life.

We offer a wide range of reliable and affordable advanced testing to support you and your patients' needs. AML Women's Health provides comprehensive support and valuable insights to help you navigate your patients' health journeys with confidence.